
    
      This is a multicenter, observational cohort trial in the real-world clinical setting
      recruiting new-onset OMG patients from Neurology Departments of 7 hospitals in different
      regions of China. Clinical manifestations, laboratory test results, chest imaging and history
      of thymectomy are recorded. Treatment option are determined according to the physician's
      judgment and preferences of the patients. Patients are followed up prospectively on regular
      to assess the outcomes of treatments and monitor any side effects. Peripheral blood samples
      are collected annually. The investigators plan to recruit a final sample of 200 patients for
      analysis.
    
  